First patient implanted in Newronika's pivotal trial of adaptive deep brain stimulation
The ADVENT study will compare adaptive and conventional DBS in 104 people with Parkinson's disease across the US and Europe.
News
The developments that matter in BCIs and neurotechnology, with context and links to the original sources.
The ADVENT study will compare adaptive and conventional DBS in 104 people with Parkinson's disease across the US and Europe.
The Series D values the maker of the Layer 7 Cortical Interface at about $1 billion and brings its total funding to $430 million.
After stroke rehabilitation, the implant is now recognized for helping people with quadriplegia control a computer cursor with brain signals.
A participant with ALS used the N1 implant to generate synthesized speech in a voice rebuilt from earlier recordings. No peer-reviewed data has been published.
Three months after implantation, the Connexus BCI let a woman with motor neuron disease answer open-ended questions and talk with her grandchildren.
Edward Chang's team decoded concurrent speech and upper-body gestures, a step toward more natural, expressive communication BCIs.
Sam Altman's BCI start-up will use Butterfly's Ultrasound-on-Chip technology under an exclusive multi-year license to build ultrasound-based brain interfaces.
The Chengdu-based start-up, co-founded by Shanda Group's Tianqiao Chen, raised two rounds in six months to build non-invasive 'read and write' BCIs.
The Ackman Oxman Institute will focus on brain research, rehabilitation and longevity, with Mount Sinai as a clinical partner.
The wireless retinal chip, approved for vision loss from geographic atrophy, can now be sold across 30 European countries; US approval is still pending.
In an intraoperative study at TU Munich, the start-up's batteryless BCI technology captured brain signals from patients undergoing brain tumor surgery.
Feinstein Institutes researchers combined a brain implant with spinal and sensory-cortex stimulation to restore arm and hand movement and a sense of touch.
Shanghai's Huashan Hospital implanted Neuracle's NEO, the first invasive BCI cleared for sale anywhere, in a man with tetraplegia.
Surgeons at University of Michigan Health implanted the wireless device in a woman with motor neuron disease, starting the six-year Connect-One study.
In Nature Medicine, UC Davis researchers report 99% word accuracy and more than 3,800 hours of home use, including for work, without researchers present.
Using real-time fMRI, researchers showed people learn a brain-computer interface much faster when it is matched to each person's existing patterns of brain activity.
ECoG Assistant flags important intracranial EEG recordings from the RNS System, built on more than 124,000 expert-labeled records.
H.814 recognizes mental and neural data privacy and freedom of thought, and limits how neurotechnology can access or alter brain activity.
The same fully implanted Brain Interchange device used to stimulate the brain for stroke recovery also decoded the participant's intentions to control a computer.
The RESONATE study will test Motif's wirelessly powered stimulator, which sits in the skull above the brain, in people with treatment-resistant depression.
The San Francisco start-up, led by former iota Biosciences CEO Michel Maharbiz, pairs a brain interface with a motorized glove to help stroke survivors regain hand function.
The company's participant count has nearly doubled since September 2025, with studies spanning cursor control, robotic arms, speech and vision.
OpenAI is the largest investor in the seed round, led by Bain Capital. The start-up is betting on ultrasound and molecular tools instead of electrodes.
The FL-100 tDCS headset can be prescribed for moderate to severe major depression, alone or alongside medication, with US launch expected in 2026.
The Connexus high-data-rate implant can now begin a clinical study in people who have lost the ability to speak.
The Series D funds the study Synchron needs before it can ask the FDA for full market approval of the Stentrode.
All 194 member states approved a Recommendation that protects mental privacy and neural data and limits uses on children, at work and in consumer products.
In the PRIMAvera trial, 81% of participants had a meaningful gain in visual acuity at one year with Science Corp.'s PRIMA system.
The bill would have the FTC review how brain and nervous-system data is collected and used, as more states pass their own neural privacy laws.
The EMG wristband that ships with Meta Ray-Ban Display glasses reads muscle signals to turn tiny finger movements into commands.
No stories with that tag yet.
Prefer a feed? Subscribe via RSS.